Latest Blogs

Nov 20, 2018
 Although there are still several weeks left in 2018, events have left me speechless twice this year: the deaths of two women, well before their time.
Nov 20, 2018
Attending the ASCO Annual Meeting was a great reminder of the importance of our social media-based networking; each time I “met” a HOWPG member for the first time, it felt like meeting a close old friend.
Nov 20, 2018
To rescue someone on the precipice takes courage, with strong doses of love, acceptance, and supported choices and, above all, trust and hopefulness.
Nov 19, 2018
At a recent meeting, the ASCO delegation to the AMA House of Delegates presented concerns focused on the Competitive Acquisition Program (CAP), among a variety of other issues.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Oct 31, 2014
How to answer this very common question is a pretty daunting task. Last week, I was at the Prostate Cancer Foundation annual scientific retreat. This is the ultimate place...
Jul 22, 2014
The use of statins to control dyslipidemia is now over 20 years old and supported for patients with coronary artery disease by the landmark Scandanavian Simvastatin Survival Study published in 1994....
Jun 02, 2014
Adding 6 cycles of docetaxel at the outset of hormonal therapy for prostate cancer has been shown to improve survival, especially in men with a high burden of disease. The much-...
Apr 18, 2014
So how did the robot take over? As I recall, it started with "hospital A" buying the fancy robot for their urologists to use, after said urologists insisted that this was the way of the future. The Intuitive Surgical Company did an...
Mar 10, 2014
A new article appeared this week with further fuel for those on the side of intervention (and by implication, pro-screening). Let's remember before we get started that the two...
Feb 07, 2014
Long, long ago, I had just finished my fellowship in medical oncology and moved from Boston to Denver. In the lab, I was working on an obscure enzyme that seemed to differentiate leukemia from normal cells,cystathionase. In...

Pages